Luis Miguel
Antón Aparicio
Hospital Universitario de Guadalajara
Guadalajara, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario de Guadalajara (8)
2017
-
Tyrosine kinase inhibitors reprogramming immunity in renal cell carcinoma: rethinking cancer immunotherapy
Clinical and Translational Oncology, Vol. 19, Núm. 10, pp. 1175-1182
2016
-
Role of taxanes in advanced prostate cancer
Clinical and Translational Oncology, Vol. 18, Núm. 10, pp. 972-980
2011
-
Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients
Expert Opinion on Pharmacotherapy, Vol. 12, Núm. 16, pp. 2433-2439
2009
-
Prostate stem cells and cell differentiation
Handbook of Prostate Cancer Cell Research: Growth, Signalling, and Survival (Nova Science Publishers, Inc.), pp. 211-241
-
The role of COX-2 in prostate carcinoma: Therapeutical implications
Handbook of Prostate Cancer Cell Research: Growth, Signalling, and Survival (Nova Science Publishers, Inc.), pp. 363-388
2007
-
Cyclooxygenase-2 (COX-2): A molecular target in prostate cancer
Clinical and Translational Oncology, Vol. 9, Núm. 11, pp. 694-702
-
Prostate cancer and Hedgehog signalling pathway
Clinical and Translational Oncology, Vol. 9, Núm. 7, pp. 420-428
-
Prostate carcinoma and stem cells
Clinical and Translational Oncology, Vol. 9, Núm. 2, pp. 66-76